|
1
|
Gabay C: Interleukin-6 and chronic
inflammation. Arthritis Res Ther. 8:S32006. View Article : Google Scholar
|
|
2
|
Abdelaziz DH, Gavrilin MA, Akhter A,
Caution K, Kotrange S, Khweek AA, Abdulrahman BA, Grandhi J, Hassan
ZA, Marsh C, et al: Apoptosis-associated speck-like protein (ASC)
controls Legionella pneumophila infection in human
monocytes. J Biol Chem. 286:3203–3208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Masumoto J, Taniguchi S, Ayukawa K,
Sarvotham H, Kishino T, Niikawa N, Hidaka E, Katsuyama T, Higuchi T
and Sagara J: ASC, a novel 22-kDa protein, aggregates during
apoptosis of human promyelocytic leukemia HL-60 cells. J Biol Chem.
274:33835–33838. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Petrilli V, Papin S and Tschopp J: The
inflammasome. Curr Biol. 15:R5812005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fernandes-Alnemri T, Wu J, Yu JW, Datta P,
Miller B, Jankowski W, Rosenberg S, Zhang J and Alnemri ES: The
pyroptosome: a supramolecular assembly of ASC dimers mediating
inflammatory cell death via caspase-1 activation. Cell Death
Differ. 14:1590–1604. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Srinivasula SM, Poyet JL, Razmara M, Datta
P, Zhang Z and Alnemri ES: The PYRIN-CARD protein ASC is an
activating adaptor for Caspase-1. J Biol Chem. 277:21119–21122.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu HB and Finlay BB: The Caspase-1
inflammasome: a pilot of innate immune responses. Cell Host
Microbe. 4:198–208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akhter A, Gavrilin MA, Frantz L,
Washington S, Ditty C, Limoli D, Day C, Sarkar A, Newland C,
Butchar J, et al: Caspase-7 activation by the Nlrc4/Ipaf
inflammasome restricts Legionella pneumophila infection.
PLoS Pathog. 5:e10003612009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lamkanfi M, Kanneganti TD, Van Damme P,
Vanden Berghe T, Vanoverberghe I, Vandekerckhove J, Vandenabeele P,
Gevaert K and Núñez G: Targeted peptidecentric proteomics reveals
Caspase-7 as a substrate of the Caspase-1 inflammasomes. Mol Cell
Proteomics. 7:2350–2363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lamkanfi M, Moreira LO, Makena P,
Spierings DC, Boyd K, Murray PJ, Green DR and Kanneganti TD:
Caspase-7 deficiency protects from endotoxin-induced lymphocyte
apoptosis and improves survival. Blood. 113:2742–2745. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Franchi L, Eigenbrod T, Planillo RM and
Nuñez G: The inflammasome: a caspase-1 activation platform
regulating immune responses and disease pathogenesis. Nat Immunol.
10:241–247. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martinon F and Tschopp J: Inflammatory
caspases and inflammasomes: master switches of inflammation. Cell
Death Differ. 14:10–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nicholson DW: Caspase structure,
proteolytic substrates, and function during apoptotic cell death.
Cell Death Differ. 6:1028–1042. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cerretti DP, Kozlosky CJ, Mosley B, et al:
Molecular cloning of the interleukin-1 beta converting enzyme.
Science. 256:97–100. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thornberry NA, Bull HG, Calaycay JR, et
al: A novel heterodimeric cysteine protease is required for
interleukin-1 beta processing in monocytes. Nature. 356:768–774.
1992. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martinon F and Tschopp J: Inflammatory
caspases: linking an intracellular innate immune system to
autoinflammatory diseases. Cell. 117:561–574. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Netea MG, Nold-Petry CA, Nold MF, et al:
Differential requirement for the activation of the inflammasome for
processing and release of IL-1{beta} in monocytes and macrophages.
Blood. 113:2324–2335. 2009.PubMed/NCBI
|
|
18
|
Kuijk LM, Beekman JM, Koster J, Waterham
HR, Frenkel J and Coffer PJ: HMG-CoA reductase inhibition induces
IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1
activation. Blood. 112:3563–3573. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Srinivasula SM, Poyet JL, Razmara M, Datta
P, Zhang Z and Alnemri ES: The PYRIN-CARD protein ASC is an
activating adaptor for caspase-1. J Biol Chem. 277:21119–21122.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stehlik C, Lee SH, Dorfleutner A,
Stassinopoulos A, Sagara J and Reed JC: Apoptosis-associated
Speck-like protein containing a caspase recruitment domain is a
regulator of procaspase-1 activation. J Immunol. 171:6154–6163.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brodsky IE and Monack D: NLR-mediated
control of inflammasome assembly in the host response against
bacterial pathogens. Semin Immunol. 21:199–207. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Broz P, Moltke J, Jones JW, Vance R and
Monack DM: Differential requirement for Caspase-1 autoproteolysis
in pathogen-induced cell death and cytokine processing. Cell Host
Microbe. 8:471–483. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mengshol JA, Vincenti MP, Coon CI,
Barchowsky A and Brinckerhoff CE: Interleukin-1 induction of
collagenase 3 (matrix metalloproteinase 13) gene expression in
chondrocytes requires p38, c-jun N-terminal kinase, and nuclear
factor κB: differential regulation of collagenase 1 and collagenase
3. Arthritis Rheum. 43:801–811. 2000.
|
|
24
|
Hagemann T, Biswas SK, Lawrence T, Sica A
and Lewis CE: Regulation of macrophage function in tumors: the
multifaceted role of NF-κB. Blood. 113:3139–3146. 2009.PubMed/NCBI
|
|
25
|
Karin M and Greten FR: NF-κB: linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005.
|
|
26
|
Biswas S and Lewis CE: NF-κB as a central
regulator of macrophage function in tumors mechanism and repertoire
of ASC-mediated gene expression. JLB. 88:877–884. 2010.
|
